EphA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer

G. Martini; C. Cardone; P.P. Vitiello; V. Belli; S. Napolitano; T. Troiani; D. Ciardiello; C.M. Della Corte; F. Morgillo; N. Matrone; V. Sforza; G. Papaccio; V. Desiderio; M.C. Paul; V. Moreno-Viedma; N. Normanno; A.M. Rachiglio; V. Tirino; E. Maiello; T.P. Latiano; D. Rizzi; G. Signoriello; M. Sibilia; F. Ciardiello; E. Martinelli

doi:10.1158/1535-7163.MCT-18-0539

EphA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer

G. Martini, C. Cardone, P.P. Vitiello, V. Belli, S. Napolitano, T. Troiani, D. Ciardiello, C.M. Della Corte, F. Morgillo, N. Matrone, V. Sforza, G. Papaccio, V. Desiderio, M.C. Paul, V. Moreno-Viedma, N. Normanno, A.M. Rachiglio, V. Tirino, E. Maiello, T.P. LatianoD. Rizzi, G. Signoriello, M. Sibilia, F. Ciardiello, E. Martinelli

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	845-855
Number of pages	11
Journal	Molecular Cancer Therapeutics
Volume	18
Issue number	4
DOIs	https://doi.org/10.1158/1535-7163.MCT-18-0539
Publication status	Published - 2019

Access to Document

10.1158/1535-7163.MCT-18-0539

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064198332&doi=10.1158%2f1535-7163.MCT-18-0539&partnerID=40&md5=b35dfb1d443d90993c6314486b063160

Cite this

Martini, G., Cardone, C., Vitiello, P. P., Belli, V., Napolitano, S., Troiani, T., Ciardiello, D., Della Corte, C. M., Morgillo, F., Matrone, N., Sforza, V., Papaccio, G., Desiderio, V., Paul, M. C., Moreno-Viedma, V., Normanno, N., Rachiglio, A. M., Tirino, V., Maiello, E., ... Martinelli, E. (2019). EphA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer. Molecular Cancer Therapeutics, 18(4), 845-855. https://doi.org/10.1158/1535-7163.MCT-18-0539

EphA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer. / Martini, G.; Cardone, C.; Vitiello, P.P.; Belli, V.; Napolitano, S.; Troiani, T.; Ciardiello, D.; Della Corte, C.M.; Morgillo, F.; Matrone, N.; Sforza, V.; Papaccio, G.; Desiderio, V.; Paul, M.C.; Moreno-Viedma, V.; Normanno, N.; Rachiglio, A.M.; Tirino, V.; Maiello, E.; Latiano, T.P.; Rizzi, D.; Signoriello, G.; Sibilia, M.; Ciardiello, F.; Martinelli, E.

In: Molecular Cancer Therapeutics, Vol. 18, No. 4, 2019, p. 845-855.

Research output: Contribution to journal › Article › peer-review

Martini, G, Cardone, C, Vitiello, PP, Belli, V, Napolitano, S, Troiani, T, Ciardiello, D, Della Corte, CM, Morgillo, F, Matrone, N, Sforza, V, Papaccio, G, Desiderio, V, Paul, MC, Moreno-Viedma, V, Normanno, N , Rachiglio, AM, Tirino, V, Maiello, E , Latiano, TP, Rizzi, D, Signoriello, G, Sibilia, M, Ciardiello, F & Martinelli, E 2019, 'EphA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer', Molecular Cancer Therapeutics, vol. 18, no. 4, pp. 845-855. https://doi.org/10.1158/1535-7163.MCT-18-0539

Martini, G. ; Cardone, C. ; Vitiello, P.P. ; Belli, V. ; Napolitano, S. ; Troiani, T. ; Ciardiello, D. ; Della Corte, C.M. ; Morgillo, F. ; Matrone, N. ; Sforza, V. ; Papaccio, G. ; Desiderio, V. ; Paul, M.C. ; Moreno-Viedma, V. ; Normanno, N. ; Rachiglio, A.M. ; Tirino, V. ; Maiello, E. ; Latiano, T.P. ; Rizzi, D. ; Signoriello, G. ; Sibilia, M. ; Ciardiello, F. ; Martinelli, E. / EphA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer. In: Molecular Cancer Therapeutics. 2019 ; Vol. 18, No. 4. pp. 845-855.

@article{d8617a78a22241d59fa7a52858fdf2c1,

title = "EphA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer",

author = "G. Martini and C. Cardone and P.P. Vitiello and V. Belli and S. Napolitano and T. Troiani and D. Ciardiello and {Della Corte}, C.M. and F. Morgillo and N. Matrone and V. Sforza and G. Papaccio and V. Desiderio and M.C. Paul and V. Moreno-Viedma and N. Normanno and A.M. Rachiglio and V. Tirino and E. Maiello and T.P. Latiano and D. Rizzi and G. Signoriello and M. Sibilia and F. Ciardiello and E. Martinelli",

note = "Export Date: 26 June 2019",

year = "2019",

doi = "10.1158/1535-7163.MCT-18-0539",

language = "English",

volume = "18",

pages = "845--855",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "4",

}

TY - JOUR

T1 - EphA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer

AU - Martini, G.

AU - Cardone, C.

AU - Vitiello, P.P.

AU - Belli, V.

AU - Napolitano, S.

AU - Troiani, T.

AU - Ciardiello, D.

AU - Della Corte, C.M.

AU - Morgillo, F.

AU - Matrone, N.

AU - Sforza, V.

AU - Papaccio, G.

AU - Desiderio, V.

AU - Paul, M.C.

AU - Moreno-Viedma, V.

AU - Normanno, N.

AU - Rachiglio, A.M.

AU - Tirino, V.

AU - Maiello, E.

AU - Latiano, T.P.

AU - Rizzi, D.

AU - Signoriello, G.

AU - Sibilia, M.

AU - Ciardiello, F.

AU - Martinelli, E.

N1 - Export Date: 26 June 2019

PY - 2019

Y1 - 2019

U2 - 10.1158/1535-7163.MCT-18-0539

DO - 10.1158/1535-7163.MCT-18-0539

M3 - Article

VL - 18

SP - 845

EP - 855

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 4

ER -